{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:25:29Z","timestamp":1769084729218,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1552,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Province","doi-asserted-by":"publisher","award":["201318101-12"],"award-info":[{"award-number":["201318101-12"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["201804010214"],"award-info":[{"award-number":["201804010214"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2012J4100035"],"award-info":[{"award-number":["2012J4100035"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2014A020212372"],"award-info":[{"award-number":["2014A020212372"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["S2011040004458"],"award-info":[{"award-number":["S2011040004458"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100235"],"award-info":[{"award-number":["81100235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Province","doi-asserted-by":"publisher","award":["201318101\u201012"],"award-info":[{"award-number":["201318101\u201012"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["201804010214"],"award-info":[{"award-number":["201804010214"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2012J4100035"],"award-info":[{"award-number":["2012J4100035"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2014A020212372"],"award-info":[{"award-number":["2014A020212372"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["S2011040004458"],"award-info":[{"award-number":["S2011040004458"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100235"],"award-info":[{"award-number":["81100235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Rheumatic heart disease (RHD) remains a major global health problem. Renin\u2013angiotensin\u2013aldosterone system inhibitors (RAASi) are commonly administered in the treatment of cardiovascular disease, but its role in RHD patients is still limited. We performed a retrospective study to determine the effect of RAASi on long-term outcomes for RHD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A 1:1 propensity score matching was implemented to balance baseline characteristics between groups RAASi and non-RAASi. Cox proportional hazards regression model was used to investigate the associations of RAASi with the risks of all-cause mortality, cardiovascular death (CVD), and cerebrovascular death. Binary logistic regression analysis was used to evaluate the associations of RAASi with the risks of 1, 3, and 5 year heart failure (HF) rehospitalization, new-onset atrial fibrillation (AF), and new-onset stroke. A total of 734 RHD patients were enrolled as study participants; nearly half of these participants had combined valve damage (54.4%), worse New York Heart Association functional class status (III and IV, 55.2%), surgical treatment (54.2%), and AF (65.0%). After propensity score matching, 514 RHD patients were finally analysed. RAASi treatment was associated with decreased risks of all-cause mortality [adjusted hazard ratio (HR) = 0.52, 95% confidence interval (CI): 0.37\u20130.73, P &amp;lt; 0.001], CVD (adjusted HR = 0.48, 95% CI: 0.30\u20130.76, P = 0.002), and cerebrovascular death (adjusted HR = 0.22, 95% CI: 0.08\u20130.60, P = 0.003). Further subgroup analysis showed that RAASi treatment was associated with decreased risks of all-cause mortality (adjusted HR = 0.50, 95% CI: 0.31\u20130.79, P = 0.004), CVD (adjusted HR = 0.48, 95% CI: 0.25\u20130.91, P = 0.025), and cerebrovascular death (adjusted HR = 0.19, 95% CI: 0.05\u20130.65, P = 0.008) in RHD patients without surgical treatment, and better effect was observed in RHD patients with surgical treatment on the risks of all-cause mortality (adjusted HR = 0.47, 95% CI: 0.26\u20130.85, P = 0.012) and CVD (adjusted HR = 0.43, 95% CI: 0.21\u20130.90, P = 0.024) except cerebrovascular death (adjusted HR = 0.52, 95% CI: 0.08\u20133.36, P = 0.491). RAASi treatment was associated with decreased HF rehospitalization risk of 1 year [adjusted odds ratio (OR) = 0.38, 95% CI: 0.23\u20130.61, P &amp;lt; 0.001], 3 year (adjusted OR = 0.43, 95% CI: 0.28\u20130.68, P &amp;lt; 0.001), and 5 year (adjusted OR = 0.48, 95% CI: 0.30\u20130.77, P = 0.002) as well as new-onset AF risk (adjusted OR = 0.38, 95% CI: 0.21\u20130.68, P = 0.001). RAASi treatment had nothing to do with new-onset stroke risk (adjusted OR = 0.80, 95% CI: 0.47\u20131.38, P = 0.428).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Renin\u2013angiotensin\u2013aldosterone system inhibitor treatment was significantly associated with decreased risks of mortality, HF rehospitalization, and new-onset AF in RHD patients in median 5.9 year follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13623","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T02:01:00Z","timestamp":1632189660000},"page":"5338-5351","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Renin-Angiotensin System Inhibitors on Long-Term Clinical Outcomes of Patients with Rheumatic Heart Disease"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0508-0129","authenticated-orcid":false,"given":"Cheng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guangzhou First People's Hospital, South China University of Technology , 1 Panfu Road, Guangzhou, 510180 ,","place":["China"]},{"name":"Department of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxian","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangzhou First People's Hospital, South China University of Technology , 1 Panfu Road, Guangzhou, 510180 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deping","family":"Wu","sequence":"additional","affiliation":[{"name":"Guangzhou Center for Disease Control and Prevention , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruibin","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The General Hospital of Southern Theater Command , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Naval Hospital of Southern Theater Command , Zhanjiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianwang","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"2026012114200258100_ehf213623-bib-0001","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012114200258100_ehf213623-bib-0002","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(16)00547-X","article-title":"Valvular aspects of rheumatic heart disease","volume":"387","author":"Remenyi","year":"2016","journal-title":"Lancet"},{"key":"2026012114200258100_ehf213623-bib-0003","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrcardio.2013.34","article-title":"Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease","volume":"10","author":"Remenyi","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0004","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012114200258100_ehf213623-bib-0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrcardio.2009.162","article-title":"Prevention and treatment of rheumatic heart disease in the developing world","volume":"6","author":"Steer","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0006","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012114200258100_ehf213623-bib-0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carpath.2011.01.005","article-title":"Adhesion molecule expression and ventricular remodeling in chronic rheumatic heart disease: a cause or effect in the disease progression--a pilot study","volume":"21","author":"Saikia","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"2026012114200258100_ehf213623-bib-0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2006.12.038","article-title":"Association of chronic subclinical inflammation with severity and progression of rheumatic valve disease","volume":"124","author":"Sari","year":"2008","journal-title":"Int J Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jtcvs.2009.10.035","article-title":"Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation","volume":"140","author":"Cong","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012114200258100_ehf213623-bib-0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","article-title":"World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline","volume":"9","author":"Remenyi","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0011","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/clinem\/dgab336","article-title":"Clinical and genetic analysis of KATP variants with heart failure risk in patients with decreased serum ApoA-I levels","volume":"106","author":"Liu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026012114200258100_ehf213623-bib-0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/M17-3203","article-title":"Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology\/American Heart Association Hypertension Guideline","volume":"168","author":"Carey","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026012114200258100_ehf213623-bib-0013","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114200258100_ehf213623-bib-0014","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1002\/ehf2.12987","article-title":"Outcomes of diuretics in rheumatic heart disease with compensated chronic heart failure: a retrospective study","volume":"7","author":"Liu","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114200258100_ehf213623-bib-0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5001\/omj.2012.68","article-title":"Type 2 diabetes mellitus: a review of current trends","volume":"27","author":"Olokoba","year":"2012","journal-title":"Oman Med J"},{"key":"2026012114200258100_ehf213623-bib-0016","article-title":"Association of KATP Gene Polymorphisms with Dyslipidemia and Ischemic Stroke Risks Among Hypertensive Patients in South China","author":"Liu","year":"2021","journal-title":"J Mol Neurosci"},{"key":"2026012114200258100_ehf213623-bib-0017","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"2026012114200258100_ehf213623-bib-0018","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the european Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114200258100_ehf213623-bib-0019","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/00015385.2017.1401275","article-title":"Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment","volume":"73","author":"Geis","year":"2018","journal-title":"Acta Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0020","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2018.18077","article-title":"Association of renin-angiotensin inhibitor treatment with mortality and Heart Failure Readmission in patients with transcatheter aortic valve replacement","volume":"320","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"2026012114200258100_ehf213623-bib-0021","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijcard.2014.09.163","article-title":"Improved prognosis following renin-angiotensin-aldosterone system blockade in patients undergoing concomitant aortic and mitral valve replacement","volume":"177","author":"Yiu","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0022","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/000331970505600205","article-title":"Safety and efficacy of enalapril in multivalvular heart disease with significant mitral stenosis--SCOPE-MS","volume":"56","author":"Chockalingam","year":"2005","journal-title":"Angiology"},{"key":"2026012114200258100_ehf213623-bib-0023","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3317\/jraas.2008.016","article-title":"Effect of losartan on exercise tolerance and echocardiographic parameters in patients with mitral regurgitation","volume":"9","author":"Sekuri","year":"2008","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026012114200258100_ehf213623-bib-0024","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/895215","article-title":"Inflammatory characteristics of stenotic aortic valves: a comparison between rheumatic and nonrheumatic aortic stenosis","volume":"2013","author":"Wallby","year":"2013","journal-title":"Cardiol Res Pract"},{"key":"2026012114200258100_ehf213623-bib-0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2003.10.017","article-title":"Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic S. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS)","volume":"147","author":"Chockalingam","year":"2004","journal-title":"Am Heart J"},{"key":"2026012114200258100_ehf213623-bib-0026","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.amjcard.2017.02.037","article-title":"Effect of renin-angiotensin blockers on left ventricular remodeling in severe aortic stenosis","volume":"119","author":"Goh","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0027","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jacc.2011.07.043","article-title":"The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study","volume":"58","author":"Elder","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0028","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.echo.2015.12.012","article-title":"Survival in patients with degenerative mitral stenosis: results from a large retrospective cohort study","volume":"29","author":"Pasca","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012114200258100_ehf213623-bib-0029","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/CIRCULATIONAHA.115.016006","article-title":"Drug therapy for heart valve diseases","volume":"132","author":"Borer","year":"2015","journal-title":"Circulation"},{"key":"2026012114200258100_ehf213623-bib-0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/bjh.14969","article-title":"Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients","volume":"179","author":"Haymann","year":"2017","journal-title":"Br J Haematol"},{"key":"2026012114200258100_ehf213623-bib-0031","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012114200258100_ehf213623-bib-0032","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12872-015-0094-1","article-title":"A review of outcome following valve surgery for rheumatic heart disease in Australia","volume":"15","author":"Russell","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012114200258100_ehf213623-bib-0033","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jcin.2014.02.011","article-title":"Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations","volume":"7","author":"Lindman","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012114200258100_ehf213623-bib-0034","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0735-1097(02)01766-7","article-title":"Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation","volume":"39","author":"Gaasch","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/clc.22019","article-title":"Favorable effects of vasodilators on left ventricular remodeling in asymptomatic patients with chronic moderate-severe aortic regurgitation and normal ejection fraction: a meta-analysis of clinical trials","volume":"35","author":"Shah","year":"2012","journal-title":"Clin Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0036","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/ejcts\/ezv307","article-title":"Right ventricular function in patients undergoing surgical or transcatheter aortic valve replacement","volume":"49","author":"Demirkol","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012114200258100_ehf213623-bib-0037","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1510\/icvts.2009.206607","article-title":"Pulmonary arterial hypertension in rheumatic mitral stenosis: does it affect right ventricular function and outcome after mitral valve replacement?","volume":"9","author":"Pande","year":"2009","journal-title":". Interact Cardiovasc Thorac Surg"},{"key":"2026012114200258100_ehf213623-bib-0038","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijcard.2008.06.027","article-title":"Right ventricular ejection fraction and enalapril","volume":"138","author":"Perez-Calvo","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0039","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","article-title":"Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial","volume":"127","author":"van der Bom","year":"2013","journal-title":"Circulation"},{"key":"2026012114200258100_ehf213623-bib-0040","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003721","article-title":"Angiotensin-receptor blocker, angiotensin-converting enzyme inhibitor, and risks of atrial fibrillation: a Nationwide cohort study","volume":"95","author":"Hsieh","year":"2016","journal-title":"Med (Baltimore)"},{"key":"2026012114200258100_ehf213623-bib-0041","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2026012114200258100_ehf213623-bib-0042","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13019-017-0627-z","article-title":"Late outcome of surgical radiofrequency ablation for persistent valvular atrial fibrillation in China: a single-center study","volume":"12","author":"Cao","year":"2017","journal-title":"J Cardiothorac Surg"},{"key":"2026012114200258100_ehf213623-bib-0043","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/europace\/eux240","article-title":"Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)","volume":"19","author":"Lip","year":"2017","journal-title":"Europace"},{"key":"2026012114200258100_ehf213623-bib-0044","doi-asserted-by":"crossref","first-page":"31042","DOI":"10.1038\/srep31042","article-title":"Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation","volume":"6","author":"Hamatani","year":"2016","journal-title":"Sci Rep"},{"key":"2026012114200258100_ehf213623-bib-0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/TH15-12-0923","article-title":"Left atrial size and risk of stroke in patients in sinus rhythm. a systematic review","volume":"116","author":"Overvad","year":"2016","journal-title":"Thromb Haemost"},{"key":"2026012114200258100_ehf213623-bib-0046","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvv001","article-title":"Atrial fibrillation: effects beyond the atrium?","volume":"105","author":"Wijesurendra","year":"2015","journal-title":"Cardiovasc Res"},{"key":"2026012114200258100_ehf213623-bib-0047","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/clc.22715","article-title":"DNA methylation dysregulations in valvular atrial fibrillation","volume":"40","author":"Shen","year":"2017","journal-title":"Clin Cardiol"},{"key":"2026012114200258100_ehf213623-bib-0048","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2016.02.002","article-title":"Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation","volume":"175","author":"Roberts","year":"2016","journal-title":"Am Heart J"},{"key":"2026012114200258100_ehf213623-bib-0049","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12872-021-01915-9","article-title":"Association of ACE2 variant rs4646188 with the risks of atrial fibrillation and cardioembolic stroke in uygur patients with type 2 diabetes","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012114200258100_ehf213623-bib-0050","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","article-title":"Stroke risk factors, genetics, and prevention","volume":"120","author":"Boehme","year":"2017","journal-title":"Circ Res"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13623","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13623","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/6\/5338\/65569478\/eschf_8_6_5338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/6\/5338\/65569478\/eschf_8_6_5338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:24:07Z","timestamp":1769023447000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/6\/5338\/8343753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,9,20]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13623","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"2021-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}